In a 14‑year‑old boy undergoing pre‑sport screening with a murmur, a family history of early sudden death, and a prolonged QT interval on ECG, what is the appropriate management and sports restriction?

Management of 14-Year-Old Boy with Long QT Syndrome and Family History of Sudden Death

This adolescent must immediately stop all competitive sports, begin beta-blocker therapy, and remain restricted from competitive athletics until he completes comprehensive evaluation, initiates appropriate treatment, and stays asymptomatic on therapy for at least 3 months. 1

Immediate Actions Required

Sports Restriction

• All competitive sport participation must cease immediately and remain prohibited until the complete evaluation and treatment protocol is finished (Class I recommendation from the American Heart Association/American College of Cardiology). 1
• The combination of long QT on ECG, family history of sudden death at age 40, male sex, and age 14 creates an exceptionally high-risk profile that demands immediate intervention. 1
• Age 14 represents a particularly high-risk period for sudden cardiac death in LQTS patients. 1

Beta-Blocker Therapy

• Beta-blocker therapy is mandatory first-line treatment for all patients with electrocardiographically documented LQTS and reduces adverse cardiac events by more than 75%. 1
• Nadolol is the preferred agent, with propranolol and atenolol as acceptable alternatives; metoprolol should be avoided due to lower effectiveness. 1
• Beta-blocker therapy alone does NOT justify immediate return to competitive sports and does not guarantee safety for vigorous activity. 1

Essential Workup Before Any Sports Consideration

• Echocardiography is required to evaluate the murmur and exclude structural heart disease such as hypertrophic cardiomyopathy. 1
• Comprehensive genetic testing (Class I recommendation) is mandatory to identify the specific LQTS subtype, which determines trigger-specific activity restrictions. 1
• Evaluation by a cardiac channelopathy specialist or genetic cardiologist with expertise in channelopathies is required. 1

Future Sports Participation (Only After Initial Management)

Conditions That Must Be Met

• After ≥3 months of remaining asymptomatic on beta-blocker therapy, sports participation "may be considered" through shared decision-making (Class IIb recommendation). 1
• This represents a nuanced shift from older European guidelines (2005) that imposed blanket restrictions, reflecting low event rates in properly treated patients. 1

Permitted Activities (If Cleared After 3 Months)

• Only low-intensity activities are appropriate: brisk walking, bowling, and golf (rated 5/5 safety). 1
• Moderate-intensity activities like doubles tennis and modest hiking may be permitted with extreme caution (rated 4-5/5). 1

Strictly Contraindicated Activities

• High-intensity burst activities remain absolutely prohibited even after treatment: basketball, soccer, tennis singles, sprinting (rated 0-2/5). 1
• Swimming is specifically contraindicated, particularly for LQT1 genotype, due to strong association with sudden death (rated 0/5). 1
• Competitive sports with burst exertion, activities with exposure to abrupt loud noises, and scuba diving are contraindicated. 1

Safety Requirements If Sports Are Permitted

• Personal automated external defibrillator (AED) must be part of personal sports safety gear. 1
• Emergency action plan must be established with school/team officials. 1
• Continued beta-blocker therapy with documented compliance is essential. 1

Mandatory Precautions During Treatment

• Strict avoidance of all QT-prolonging medications (check www.crediblemeds.org before prescribing any medication, including antibiotics, antihistamines, antipsychotics, and antidepressants). 1
• Regular electrolyte monitoring and aggressive hydration to prevent dehydration. 1
• Maintain normal potassium and magnesium levels, as hypokalemia can precipitate torsades de pointes. 1
• Prevention of hyperthermia from fever or heat exposure. 1

Therapy Intensification Criteria

• If syncope or cardiac events occur despite adequate beta-blocker therapy, intensification is mandatory: options include adding medications, left cardiac sympathetic denervation (which reduces ventricular arrhythmia burden by up to 73%), or ICD implantation. 1
• Asymptomatic patients with QTc >500 ms while on beta-blockers may require therapy intensification. 1
• ICD (not a pacemaker) is indicated for patients who experience syncope or cardiac arrest despite optimal beta-blocker therapy. 1

Critical Pitfalls to Avoid

• Do not assume that availability of an ICD or AED justifies unrestricted sport participation—these devices are not prospective treatment strategies that permit high-risk activities. 1
• Do not assume asymptomatic status equals low risk: up to 25-36% of genotype-positive patients with resting QTc ≤440 ms still have adverse events. 1
• Even a normal QTc does not guarantee low risk in genetically confirmed LQTS. 1

Answer to the Question

Option B is the closest to correct management: give beta-blocker and restrict to only low-effort sports—but only after ≥3 months of asymptomatic treatment, comprehensive evaluation by a channelopathy specialist, genetic testing, echocardiography to evaluate the murmur, establishment of an emergency action plan, and availability of a personal AED. 1

Option C (pacemaker) is incorrect: ICD (not pacemaker) is reserved for patients with syncope/cardiac arrest despite beta-blockers or as secondary prevention after cardiac arrest. 1

Options A and D are dangerous: they fail to recognize the high-risk profile and the mandatory need for immediate sports restriction and beta-blocker therapy. 1